GALMED PHARMACEUTICALS LTD's ticker is GLMD and the CUSIP is M47238106. A total of 20 filers reported holding GALMED PHARMACEUTICALS LTD in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $57,000 | +147.8% | 6,327 | +22.2% | 0.00% | – |
| Q2 2016 | $23,000 | -11.5% | 5,176 | 0.0% | 0.00% | – |
| Q1 2016 | $26,000 | -33.3% | 5,176 | 0.0% | 0.00% | – |
| Q4 2015 | $39,000 | -22.0% | 5,176 | -23.8% | 0.00% | – |
| Q3 2015 | $50,000 | +31.6% | 6,793 | +76.4% | 0.00% | – |
| Q2 2015 | $38,000 | – | 3,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 1,347,755 | $574,818 | 0.02% |
| Virtu Financial LLC | 31,633 | $13 | 0.00% |
| Western Wealth Management, LLC | 29,537 | $12,597 | 0.00% |
| Belpointe Asset Management LLC | 14,050 | $5,992 | 0.00% |
| TSFG, LLC | 3,000 | $1 | 0.00% |
| ZRC WEALTH MANAGEMENT, LLC | 100 | $43 | 0.00% |
| Allworth Financial LP | 250 | $107 | 0.00% |
| JANE STREET GROUP, LLC | 13,189 | $5,625 | 0.00% |
| RAYMOND JAMES & ASSOCIATES | 138,040 | $58,874 | 0.00% |
| BOURGEON CAPITAL MANAGEMENT LLC | 500 | $214 | 0.00% |